Those Who Invested in Universal Health Services (NYSE:UHS) Three Years Ago Are up 65%
Those Who Invested in Universal Health Services (NYSE:UHS) Three Years Ago Are up 65%
It hasn't been the best quarter for Universal Health Services, Inc. (NYSE:UHS) shareholders, since the share price has fallen 13% in that time. But over three years, the returns would have left most investors smiling In the last three years the share price is up, 63%: better than the market.
對於Universal Health Services,Inc.(NYSE:UHS)股東來說,這並不是最好的一個季度,因爲股價在此期間下跌了13%。 但在過去的三年裏,回報率可能會讓大多數投資者微笑。在過去的三年裏,股價上漲了63%:優於市場。
Let's take a look at the underlying fundamentals over the longer term, and see if they've been consistent with shareholders returns.
讓我們長期看一下潛在的基本面,看看它們是否與股東回報一致。
While the efficient markets hypothesis continues to be taught by some, it has been proven that markets are over-reactive dynamic systems, and investors are not always rational. One flawed but reasonable way to assess how sentiment around a company has changed is to compare the earnings per share (EPS) with the share price.
雖然一些人仍然在教授高效市場假說,但已經證明市場是過度反應的動態系統,投資者不總是理性的。一種有缺陷但合理的評估公司情緒變化的方法是比較每股收益 (EPS) 與股價。
During three years of share price growth, Universal Health Services achieved compound earnings per share growth of 7.3% per year. This EPS growth is lower than the 18% average annual increase in the share price. This suggests that, as the business progressed over the last few years, it gained the confidence of market participants. That's not necessarily surprising considering the three-year track record of earnings growth.
在股價增長的三年期間,Universal Health Services實現了每股收益的複合增長率爲7.3%。 這種每股收益增長低於股價平均年增長率的18%。 這表明,隨着業務在過去幾年的進展,它贏得了市場參與者的信任。 考慮到過去三年收益增長的記錄,這並不奇怪。
The image below shows how EPS has tracked over time (if you click on the image you can see greater detail).
下圖顯示了EPS隨時間的變化情況(如果您單擊該圖像,則可以查看更多詳細信息)。
We know that Universal Health Services has improved its bottom line lately, but is it going to grow revenue? Check if analysts think Universal Health Services will grow revenue in the future.
我們知道universal health services最近改善了其底線,但它的營業收入會增長嗎? 檢查分析師是否認爲universal health services未來會增長營業收入。
What About Dividends?
關於分紅派息的問題
It is important to consider the total shareholder return, as well as the share price return, for any given stock. Whereas the share price return only reflects the change in the share price, the TSR includes the value of dividends (assuming they were reinvested) and the benefit of any discounted capital raising or spin-off. So for companies that pay a generous dividend, the TSR is often a lot higher than the share price return. In the case of Universal Health Services, it has a TSR of 65% for the last 3 years. That exceeds its share price return that we previously mentioned. This is largely a result of its dividend payments!
考慮任何給定股票的總股東回報以及股價回報是很重要的。而股價回報僅反映了股價的變化,TSR則包括了股息的價值(假設它們已經再投資)以及任何折扣後的資本籌集或分拆的好處。因此,對於支付豐厚股息的公司,TSR通常比股價回報高得多。就universal health services而言,過去3年的TSR爲65%。這超過了我們之前提到的股價回報。這在很大程度上是其股息支付的結果!
A Different Perspective
另一種看法
We're pleased to report that Universal Health Services shareholders have received a total shareholder return of 47% over one year. And that does include the dividend. Since the one-year TSR is better than the five-year TSR (the latter coming in at 8% per year), it would seem that the stock's performance has improved in recent times. Given the share price momentum remains strong, it might be worth taking a closer look at the stock, lest you miss an opportunity. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. Take risks, for example - Universal Health Services has 1 warning sign we think you should be aware of.
我們很高興地報告,universal health services股東在一年內獲得了總股東回報率達47%。並且這包括了股息。由於一年的TSR優於五年的TSR(後者爲每年8%),似乎股票的表現近來有所改喹。鑑於股價勢頭依然強勁,值得更加仔細地研究這支股票,以免錯失機會。我發現長期來看股價作爲業務表現的替代指標非常有趣。但要真正獲得見解,我們也需要考慮其他信息。例如承擔風險 - universal health services有1個警告標誌,我們認爲您應該注意。
If you are like me, then you will not want to miss this free list of undervalued small caps that insiders are buying.
如果您和我一樣,那麼您一定不想錯過這份免費的被內部人員買入的低估小盤股清單。
Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges.
請注意,本文所引述的市場回報反映了目前在美國交易所上市的股票的市場加權平均回報。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
對這篇文章有反饋嗎?對內容感到擔憂嗎?請直接與我們聯繫。或者,發送電子郵件至editorial-team @ simplywallst.com。
Simply Wall St的這篇文章是一般性質的。我們僅基於歷史數據和分析師預測提供評論,使用公正的方法,我們的文章並非意在提供財務建議。這並不構成買入或賣出任何股票的建議,並且不考慮您的目標或財務狀況。我們旨在爲您帶來基於基礎數據驅動的長期聚焦分析。請注意,我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St對提及的任何股票都沒有持倉。
譯文內容由第三人軟體翻譯。